Managing CNS diseases at the point of diagnosis in ALK + NSCLC
Early management of CNS metastases in ALK-positive NSCLC using next-gen ALK inhibitors improves intracranial control and patient outcomes.
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
Explore unmet needs in ALK-positive NSCLC, including resistance, CNS metastases, biomarker-driven therapies, and advances in precision oncology.
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
Explore innovative strategies for early CNS disease detection, integrating neuroimaging, biomarkers, and clinical assessment to enhance diagnostic precision and outcomes.
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
Explore treatment sequencing strategies for ALK+ NSCLC patients with CNS diseases, focusing on targeted therapies and CNS-penetrant treatments.
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
In this webinar, a detailed discussion is done on Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
Explore Lorlatinib’s role in first-line ALK+ mNSCLC treatment, highlighting key findings from the CROWN trial.`
Speakers : Dr. Davinder Paul - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Randeep Singh - Panelist ,Dr. Sushant Mittal - Moderator
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
Explore key findings from the CROWN trial for ALK+ NSCLC patients with CNS metastases and treatment advances.
Speakers : Dr. Sushant Mittal - Moderator ,Dr. Randeep Singh - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Davinder Paul - Panelist
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
Expert panel discussion on on the use of palbociclib in endocrine-resistant breast cancer. Learn about the clinical trial and optimize treatment strategies.
Speakers : Dr. Srinivas K G , Dr. Abhaya Kumar S M ,Dr. Vishwanath S
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Study opens up possibility of bespoke prostate cancer treatment
2.
Why Encouragement May Not Improve Motivation in Depression
3.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
4.
A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.
5.
Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.
1.
Prevention Through Survivorship-Focused Strategies for Preserving Functional Independence After Cancer
2.
Patient Management for Bone Marrow Functional Recovery Pathways
3.
Uncovering the Causes of Thrombocytosis: A Journey to Improved Health
4.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
5.
Hematopoietic Immune Microenvironment Plasticity: Mechanisms, Clinical Implications, and Emerging Therapeutics
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
4.
Early Cancer Detection Saves Lives
5.
How Platelet Disorders Can Affect the Body
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge